Avermectin A1a

Avermectin A1a is a lipid of Polyketides (PK) class. Avermectin a1a is associated with abnormalities such as Ataxia with vitamin E deficiency, Strongyloidiasis, Congenital Transposition, Gigantism and Onchocerciasis. The involved functions are known as DNA Binding, Anabolism, Insertion Mutation, Process and physiological aspects. Avermectin a1a often locates in Chromosomes, Membrane, Clone, soluble and Tissue membrane. The associated genes with Avermectin A1a are Polypeptides, oxytocin, 1-desamino-(O-Et-Tyr)(2)-, Gene Feature, Genome and Gene Clusters. The related lipids are Propionate. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of Avermectin A1a, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Avermectin A1a?

Avermectin A1a is suspected in Ataxia with vitamin E deficiency, Gigantism, Strongyloidiasis, Congenital Transposition, Onchocerciasis, Tropical Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Avermectin A1a

MeSH term MeSH ID Detail
Inflammation D007249 119 associated lipids
Body Weight D001835 333 associated lipids
Dog Diseases D004283 5 associated lipids
Leukemia P388 D007941 43 associated lipids
Neuroblastoma D009447 66 associated lipids
Trichostrongyloidiasis D014252 7 associated lipids
Poisoning D011041 9 associated lipids
Cleft Palate D002972 9 associated lipids
Fish Diseases D005393 5 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Per page 10 20 | Total 19

PubChem Associated disorders and diseases

What pathways are associated with Avermectin A1a

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Avermectin A1a?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Avermectin A1a?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Avermectin A1a?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Avermectin A1a?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Avermectin A1a?

Mouse Model

Mouse Model are used in the study 'Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-aminobutyric acid(A) receptor.' (Dawson GR et al., 2000).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Avermectin A1a

Download all related citations
Per page 10 20 50 100 | Total 477
Authors Title Published Journal PubMed Link
Novik TS et al. [Assessment of the mutagenic activity of aversectin C]. 1999 Antibiot. Khimioter. pmid:10494378
Zhang YX et al. Genes encoding acyl-CoA dehydrogenase (AcdH) homologues from Streptomyces coelicolor and Streptomyces avermitilis provide insights into the metabolism of small branched-chain fatty acids and macrolide antibiotic production. 1999 Microbiology (Reading, Engl.) pmid:10517585
Smit JW et al. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. 1999 J. Clin. Invest. pmid:10562306
Le Jambre LF et al. Inheritance of avermectin resistance in Haemonchus contortus. 2000 Int. J. Parasitol. pmid:10675751
Kokoz YM et al. Selective cytostatic and neurotoxic effects of avermectins and activation of the GABAalpha receptors. 1999 Biosci. Rep. pmid:10841270
Gianelli L et al. Mass spectrometry of avermectins: structural determination of two new derivatives of Ivermectin B(1a). 2000 Rapid Commun. Mass Spectrom. pmid:10918377
Novotny MJ et al. Safety of selamectin in dogs. 2000 Vet. Parasitol. pmid:10940536
Krautmann MJ et al. Safety of selamectin in cats. 2000 Vet. Parasitol. pmid:10940537
Tsukamoto Y et al. Avermectin chemistry and action: ester- and ether-type candidate photoaffinity probes. 2000 Bioorg. Med. Chem. pmid:10968260
Banks BJ et al. Avermectins and flea control: structure-activity relationships and the selection of selamectin for development as an endectocide for companion animals. 2000 Bioorg. Med. Chem. pmid:11003146